Vaxart (VXRT) Revenue (2010 - 2026)
Vaxart's Revenue came in at $27.19 million for Q2 2026, down 31.6% from $39.73 million a year earlier and down 30.7% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vaxart reported Revenue of $243.06 million, up 201.1% year-over-year; for FY2025, it came in at $237.26 million, up 726.7% from FY2024.
- Revenue carries a five-year compound annual growth rate of 125.8% (FY2020 to FY2025).
- Going back by year, Revenue was $28.7 million in FY2024 (+288.9%), $7.38 million in FY2023, $107,000 in FY2022 (-88.0%) and $892,000 in FY2021 (-78.0%).
- The Q2 2026 figure represents the lowest quarterly Revenue since Q1 2025.
- Year-over-year, Revenue increased in six of the last seven quarters, with growth averaging 360.5%.
- The fastest year-over-year change in Revenue over five years came in Q1 2025 (growth of 857.2%), and the weakest in Q1 2022 (a decline of 83.2%).
- Business Quant data shows VXRT's Revenue at $39.23 million (Q1 2026), $104.24 million (Q4 2025) and $72.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Vaxart | 115.76 Mn | 51.76 Mn | - | 27.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.19 Mn |
| Mar 31, 2026 | 39.23 Mn |
| Dec 31, 2025 | 104.24 Mn |
| Sep 30, 2025 | 72.41 Mn |
| Jun 30, 2025 | 39.73 Mn |
| Mar 31, 2025 | 20.88 Mn |
| Dec 31, 2024 | 15.19 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 675,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Mar 31, 2022 | 85,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 112,000.00 |
| Mar 31, 2021 | 506,000.00 |
API Access
Vaxart Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();